KRIBIOLISA™ GCSF (Filgrastim) ELISA

ELISA Set for Accurate Quantitation from Cell Culture Supernatant, Serum, Plasma, or Other Bodily Fluids Filgrastim, sold under the brand name Neupogen among others, is a medication used to treat low neutrophil count. Low neutrophil counts may occur with HIV/AIDS, following chemotherapy or radiation poisoning, or be of an unknown cause. It may also be used to increase white blood cells for gathering during leukapheresis. It is given either by injection into a vein or under the skin. Common side effects include fever, cough, chest pain, joint pain, vomiting, and hair loss. Severe side effects include splenic rupture and allergic reactions. It is unclear if use in pregnancy is safe for the baby. Filgrastim is a recombinant-DNA form of the naturally occurring granulocyte colony-stimulating factor (G- CSF). It works by stimulating the body to increase neutrophil production. About the kit: - Uses anti-idiotypic antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity. - Recovery rates are between 85 - 115% - Ready to use with a standard protocol with break-apart pre-coated wells - Validated as per US FDA guidelines for Bioassays - Optimized for matrix effects to ensure higher sensitivity. - Shelf life: 1 year
Read more
€0.00 (tax incl.)
Reference:
KBBA14
Brand:
Product Details
KBBA14

Data sheet

Size
1 x 96 wells
Application
Assay
URL - Product
https://krishgen.com/upload/datasheets/KRIBIOLISA_GCSF_(FILGRASTIM)_KBBA14_ELISA_IFU_ver_1_1.pdf

Menu

Settings